ARMATA PHARMACEUTICALS, INC. Increase (Decrease) in Accounts Receivable
ARMATA PHARMACEUTICALS, INC. (ARMP) reported Increase (Decrease) in Accounts Receivable of $467.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-18.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2021-03-18
- ARMATA PHARMACEUTICALS, INC. increase (decrease) in accounts receivable for the quarter ending 2017-09-30 was $0.00, a 100.00% decline year-over-year.
- ARMATA PHARMACEUTICALS, INC. increase (decrease) in accounts receivable for the quarter ending 2017-06-30 was -$2.00K, a 150.00% decline year-over-year.
- ARMATA PHARMACEUTICALS, INC. increase (decrease) in accounts receivable for the quarter ending 2017-03-31 was -$10.00K.
- ARMATA PHARMACEUTICALS, INC. increase (decrease) in accounts receivable for the quarter ending 2016-12-31 was $1.00K, a 98.82% decline year-over-year.
- ARMATA PHARMACEUTICALS, INC. increase (decrease) in accounts receivable for fiscal 2020 was $467.00K.
- ARMATA PHARMACEUTICALS, INC. increase (decrease) in accounts receivable for fiscal 2016 was -$100.00K, a 500.00% decline from fiscal 2015.
- ARMATA PHARMACEUTICALS, INC. increase (decrease) in accounts receivable for fiscal 2015 was $25.00K, a 72.83% decline from fiscal 2014.
- ARMATA PHARMACEUTICALS, INC. increase (decrease) in accounts receivable for fiscal 2014 was $92.00K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2020-12-31 | $467.00K 10-K · filed 2021-03-18 | |||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | -$2.00K derived: sum of 2 quarters · filed 2017-11-14 | -$12.00K 10-Q · filed 2017-11-14 | -$11.00K derived: sum of 4 quarters · filed 2017-11-14 |
| 2017-06-30 | -$2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$12.00K 10-Q · filed 2017-08-14 | -$11.00K derived: sum of 3 quarters · filed 2017-08-14 | -$5.00K derived: sum of 4 quarters · filed 2017-11-14 |
| 2017-03-31 | -$10.00K 10-Q · filed 2017-05-15 | -$9.00K derived: sum of 2 quarters · filed 2017-05-15 | -$3.00K derived: sum of 3 quarters · filed 2017-11-14 | $1.00K derived: sum of 4 quarters · filed 2017-11-14 |
| 2016-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-27 | $7.00K derived: sum of 2 quarters · filed 2017-11-14 | $11.00K derived: sum of 3 quarters · filed 2017-11-14 | -$100.00K 10-K · filed 2017-03-27 |
| 2016-09-30 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $10.00K derived: sum of 2 quarters · filed 2017-11-14 | -$101.00K 10-Q · filed 2017-11-14 | -$16.00K derived: sum of 4 quarters · filed 2017-11-14 |
| 2016-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$107.00K 10-Q · filed 2017-08-14 | -$22.00K derived: sum of 3 quarters · filed 2017-08-14 | $18.00K derived: sum of 4 quarters · filed 2017-08-14 |
| 2016-03-31 | -$111.00K 10-Q · filed 2017-05-15 | -$26.00K derived: sum of 2 quarters · filed 2017-05-15 | $14.00K derived: sum of 3 quarters · filed 2017-05-15 | $14.00K derived: sum of 4 quarters · filed 2017-05-15 |
| 2015-12-31 | $85.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-27 | $125.00K derived: sum of 2 quarters · filed 2017-03-27 | $125.00K derived: sum of 3 quarters · filed 2017-03-27 | $25.00K 10-K · filed 2017-03-27 |
| 2015-09-30 | $40.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $40.00K derived: sum of 2 quarters · filed 2016-11-10 | -$60.00K 10-Q · filed 2016-11-10 | $13.00K derived: sum of 4 quarters · filed 2016-11-10 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | -$100.00K 10-Q · filed 2016-08-15 | -$27.00K derived: sum of 3 quarters · filed 2016-08-15 | -$136.00K derived: sum of 4 quarters · filed 2016-08-15 |
| 2015-03-31 | -$100.00K 10-Q · filed 2016-05-12 | -$27.00K derived: sum of 2 quarters · filed 2016-05-12 | -$136.00K derived: sum of 3 quarters · filed 2016-05-12 | -$12.00K derived: sum of 4 quarters · filed 2016-05-12 |
| 2014-12-31 | $73.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | -$36.00K derived: sum of 2 quarters · filed 2016-03-30 | $88.00K derived: sum of 3 quarters · filed 2016-03-30 | $92.00K 10-K · filed 2016-03-30 |
| 2014-09-30 | -$109.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | $15.00K derived: sum of 2 quarters · filed 2015-11-16 | $19.00K 10-Q · filed 2015-11-16 | -$121.00K derived: sum of 4 quarters · filed 2015-11-16 |
| 2014-06-30 | $124.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $128.00K 10-Q · filed 2015-08-13 | -$12.00K derived: sum of 3 quarters · filed 2015-08-13 | -$4.00K derived: sum of 4 quarters · filed 2015-08-13 |
| 2014-03-31 | $4.00K 10-Q · filed 2015-05-15 | -$136.00K derived: sum of 2 quarters · filed 2015-05-15 | -$128.00K derived: sum of 3 quarters · filed 2015-05-15 | $1.00K derived: sum of 4 quarters · filed 2015-05-15 |
| 2013-12-31 | -$140.00K derived: 10-Q/A 12 month − 10-Q/A 9 month · filed 2015-04-15 | -$132.00K derived: sum of 2 quarters · filed 2015-04-15 | -$3.00K derived: sum of 3 quarters · filed 2015-04-15 | -$15.00K 10-Q/A · filed 2015-04-15 |
| 2013-09-30 | $8.00K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2015-04-15 | $137.00K derived: sum of 2 quarters · filed 2015-04-15 | $125.00K 10-Q/A · filed 2015-04-15 | |
| 2013-06-30 | $129.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2015-04-15 | $117.00K 10-Q/A · filed 2015-04-15 | ||
| 2013-03-31 | -$12.00K 10-Q/A · filed 2015-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |